This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Linezolid

Read time: 1 mins
Marketing start date: 23 Dec 2024

Summary of product characteristics


Effective Time

20221013

Version

5

Spl Product Data Elements

Linezolid Linezolid LINEZOLID LINEZOLID CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE HYDROXYPROPYL CELLULOSE (1600000 WAMW) HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SILICON DIOXIDE TITANIUM DIOXIDE WHITE TO OFF-WHITE OVAL 413

Application Number

ANDA206097

Brand Name

Linezolid

Generic Name

Linezolid

Product Ndc

70771-1111

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1111-1 Linezolid Tablets, 600 mg Rx only 100 tablets Linezolid Tablets, 600mg

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.